Underpinning successful ADC development is a robust, reproducible, and scalable process development strategy. From controlling impurities and optimizing conjugation yield to streamlining unit ...
These complex biomolecules are specifically engineered to selectively deliver therapeutic agents to target cells by linking them to monoclonal antibodies. The safety profile and effectiveness of ADCs ...
With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...
The tradeoff between integrated and standalone ADCs regarding performance, specification, complexity, robustness, and cost. How to evaluate which analog technology to use to meet your application ...